• Alex Keown
• 20 Apr, 2021

Johnson & Johnson Chief Executive Officer Alex Gorsky is up for a whopping $30 million payday. However, several prominent investors are urging shareholders to reject the compensation package because it shields the executive from billions of dollars in opioid-related litigation costs to the company. J&J is a target in multiple lawsuits over the marketing of its opioid products. Despite those legal concerns and settlements of nearly $5 billion over the past two years.
Read more...